Skip to content

iTBS Intervention Study for High-Functioning Autism Spectrum Disorder Based on Neural Mechanisms of Emotion Regulation

iTBS Intervention Study for High-Functioning Autism Spectrum Disorder Based on Neural Mechanisms of Emotion Regulation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500100679
Enrollment
Unknown
Registered
2025-04-14
Start date
2025-04-25
Completion date
Unknown
Last updated
2025-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High-Functioning Autism Spectrum Disorder

Interventions

Healthy control:No treatment
Sham control group:Sham coil treatment

Sponsors

The Affiliated Kangning Hospital of Ningbo University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1.Diagnosed by two child psychiatrists as meeting the DSM-5 diagnostic criteria for autism spectrum disorder (ASD), with an intelligence quotient (IQ) >=70; 2.Aged 6-18 years, of Han ethnicity and right-handed; 3.No apparent contraindications to iTBS and willing to undergo iTBS treatment; 4.Normal findings on conventional brain MRI (including 3D BRAVO and T2-weighted imaging); 5.No contraindications for MRI scanning (e.g., claustrophobia, cardiac pacemaker implantation); 6.Head motion during fMRI scanning <2mm translation and <2° rotation;

Exclusion criteria

Exclusion criteria: 1.Evidence of organic diseases identified through physical examination or laboratory tests that could reasonably explain the severity, variability, or persistence of symptoms; 2.Presence of neurological or endocrine system disorders; 3.History of alcohol or substance abuse; 4.Previous treatment with iTBS or electroconvulsive therapy (ECT); 5.Comorbid psychiatric disorders (e.g., schizophrenia, bipolar disorder, depressive disorders), personality defects, or poor treatment adherence that may significantly affect therapeutic outcomes, behavioral assessments, or neuroimaging examinations; 6.Documented history of organic diseases (e.g., pulmonary diseases, cardiac diseases, diabetes mellitus, arthritis or osteoarthritis, rheumatic diseases, neoplasms, hypertension, gastrointestinal organic diseases, hepatic diseases, chronic fatigue syndrome, allergies, trauma, or other unspecified organic diseases).

Design outcomes

Primary

MeasureTime frame
Emotion regulation ability;

Secondary

MeasureTime frame
Social functioning;Resting-State Functional Magnetic Resonance Imaging;Emotional state;Cognitive function;

Countries

China

Contacts

Public ContactChen Lei

The Affiliated Kangning Hospital of Ningbo University

2236912002@qq.com+86 574 26302697

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026